Jenny J. Ye

Obstetrics and Gynecology

575 W Pike St
Lawrenceville, GA 30046

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study.

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study.

Journal: The Journal of investigative dermatology

Published: August 14, 2023

Considerations for pediatric trial designs and analyses.

Considerations for pediatric trial designs and analyses.

Journal: Journal of biopharmaceutical statistics

Published: September 06, 2017

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.

Journal: Diabetes care

Published: January 04, 2016

Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.

Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.

Journal: Journal of diabetes and its complications

Published: April 04, 2014

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).

Journal: Diabetes care

Published: May 01, 2013

Showing 1-5 of 5

Last Updated: 09/26/2026